|
Volumn 26, Issue 8, 2000, Pages 798-804
|
Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer
|
Author keywords
Epithelial ovarian cancer; Prognosis; Refractory ascites; Secondary cytoreductive surgery
|
Indexed keywords
ACLACINOMYCIN;
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
MITOMYCIN C;
PACLITAXEL;
PLATINUM DERIVATIVE;
VINDESINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
ASCITES FLUID CYTOLOGY;
CANCER CELL DESTRUCTION;
CANCER PALLIATIVE THERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
DISSEMINATED CANCER;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
OVARY CANCER;
PRIORITY JOURNAL;
RECURRENT CANCER;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
|
EID: 0034522765
PISSN: 07487983
EISSN: None
Source Type: Journal
DOI: 10.1053/ejso.2000.1007 Document Type: Article |
Times cited : (43)
|
References (29)
|